-
公开(公告)号：US20170304286A1
公开(公告)日：2017-10-26
申请号：US15521524
申请日：2015-10-23
发明人： Chiu-Hung Chen , Show-Mei Chuang , Tzong-Der Way , Nai-Wan Hsiao
IPC分类号： A61K31/4525 , A61K31/085
CPC分类号： A61K31/4427 , A61K31/00 , A61K31/085 , A61K31/137 , A61K31/138 , A61K31/196 , A61K31/197 , A61K31/216 , A61K31/341 , A61K31/366 , A61K31/381 , A61K31/404 , A61K31/4525 , A61K31/505 , A61K31/549 , A61K31/55 , A61K31/7056 , A61K38/00 , A61K38/02 , A61K38/05 , A61K38/14 , A61K45/06 , A61K2300/00 , C07C211/27 , C07C211/30
摘要： A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of Paroxetine or a pharmaceutical acceptable salt thereof. The cancer is selected from the group consisting of pleural-related cancer, abdominal-related cancer, endocrine-related cancer, gastrointestinal tract-related cancer, osteosarcoma, skin cancer, and blood cancer. The pleural-related cancer is lung cancer. The abdominal-related cancer is selected from bladder cancer, cervical cancer, and kidney cancer. The endocrine-related cancer is selected from prostate cancer, breast cancer, and ovarian cancer. The gastrointestinal tract-related cancer is selected from gastric cancer, hepatic cancer, colorectal cancer, pancreatic cancer, and tongue cancer.
-
公开(公告)号：US20170312260A1
公开(公告)日：2017-11-02
申请号：US15521500
申请日：2015-10-23
发明人： Chiu-Hung Chen , Show-Mei Chuang , Tzong-Der Way , Nai-Wan Hsiao
IPC分类号： A61K31/4427
CPC分类号： A61K31/4427 , A61K31/00 , A61K31/085 , A61K31/137 , A61K31/138 , A61K31/196 , A61K31/197 , A61K31/216 , A61K31/341 , A61K31/366 , A61K31/381 , A61K31/404 , A61K31/4525 , A61K31/505 , A61K31/549 , A61K31/55 , A61K31/7056 , A61K38/00 , A61K38/02 , A61K38/05 , A61K38/14 , A61K45/06 , A61K2300/00 , C07C211/27 , C07C211/30
摘要： A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of Azelnidipine or a pharmaceutical acceptable salt thereof. The cancer is selected from the group consisting of a pleural-related cancer, an abdominal-related cancer, an endocrine-related cancer, a gastrointestinal tract-related cancer, osteosarcoma, and skin cancer.
-
3.发明申请公开(公告)号：US20170304388A1
公开(公告)日：2017-10-26
申请号：US15521536
申请日：2015-10-23
IPC分类号： A61K38/05 , A61K31/7056 , A61K31/55 , A61K31/549 , A61K31/505 , A61K31/404 , A61K31/366 , A61K31/341 , A61K31/216 , A61K31/197 , A61K31/196 , A61K45/06 , A61K31/138
CPC分类号： A61K31/4427 , A61K31/00 , A61K31/085 , A61K31/137 , A61K31/138 , A61K31/196 , A61K31/197 , A61K31/216 , A61K31/341 , A61K31/366 , A61K31/381 , A61K31/404 , A61K31/4525 , A61K31/505 , A61K31/549 , A61K31/55 , A61K31/7056 , A61K38/00 , A61K38/02 , A61K38/05 , A61K38/14 , A61K45/06 , A61K2300/00 , C07C211/27 , C07C211/30
摘要： A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of a cardiovascular drug or a pharmaceutical acceptable salt thereof. The cardiovascular drug is selected from the group consisting of peripheral vasodilator reaming enhancer, angiotensin converting agent inhibitor, hypotension and shock therapeutic agent, diuretic, antiarrhythmic agent, antiarralciton drug, antihypertensive agent, anticoagulant thrombolytic agent, cardiac tonic, and intravenous (hemorrhoids) therapeutic agent. The cancer is selected from the group consisting of lung cancer, intestinal cancer, colorectal cancer, prostate cancer, liver cancer, bladder cancer, cervical cancer, breast cancer, and blood cancer.
-
4.发明授权公开(公告)号：US10105357B2
公开(公告)日：2018-10-23
申请号：US15521517
申请日：2015-10-23
IPC分类号： A61K31/505 , A61K31/4427 , A61K31/085 , A61K31/137 , C07C211/27 , C07C211/30 , A61K38/02 , A61K38/14 , A61K31/4525 , A61K31/138 , A61K31/196 , A61K31/197 , A61K31/216 , A61K31/341 , A61K31/366 , A61K31/404 , A61K31/549 , A61K31/55 , A61K31/7056 , A61K38/05 , A61K45/06 , A61K31/381 , A61K31/00 , A61K38/00
摘要： A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of an antibiotic drug or a pharmaceutical acceptable salt thereof. The antibiotic drug is selected from the group consisting of an aminoglycoside antibiotic drug, an anti-fungal antibiotic drug, a Cephalosporin antibiotic drug, a β-propionamide antibiotic drug, a chloramphenicol antibiotic drug, an erythromycin antibiotic drug, a penicillin antibiotic drug, and a tetracycline antibiotic drug.. The cancer is selected from the group consisting of lung cancer, gastrointestinal tract cancer, colorectal cancer, prostate cancer, bladder cancer, cervical cancer, breast cancer, and blood cancer.
-
公开(公告)号：US10045962B2
公开(公告)日：2018-08-14
申请号：US15492859
申请日：2017-04-20
发明人： Chiu-Hung Chen , Show-Mei Chuang , Tzong-Der Way , Nai-Wan Hsiao
IPC分类号： A61K31/38 , A61K31/381
CPC分类号： A61K31/4427 , A61K31/00 , A61K31/085 , A61K31/137 , A61K31/138 , A61K31/196 , A61K31/197 , A61K31/216 , A61K31/341 , A61K31/366 , A61K31/381 , A61K31/404 , A61K31/4525 , A61K31/505 , A61K31/549 , A61K31/55 , A61K31/7056 , A61K38/00 , A61K38/02 , A61K38/05 , A61K38/14 , A61K45/06 , A61K2300/00 , C07C211/27 , C07C211/30
摘要： Provided in the present invention are uses of duloxetine hydrochloride in preparing a pharmaceutical composition for treatment of cancer.
-
公开(公告)号：US20170304228A1
公开(公告)日：2017-10-26
申请号：US15521504
申请日：2015-10-23
发明人： Chiu-Hung Chen , Show-Mei Chuang , Tzong-Der Way , Nai-Wan Hsiao
IPC分类号： A61K31/137 , C07C211/27 , C07C211/30
CPC分类号： A61K31/4427 , A61K31/00 , A61K31/085 , A61K31/137 , A61K31/138 , A61K31/196 , A61K31/197 , A61K31/216 , A61K31/341 , A61K31/366 , A61K31/381 , A61K31/404 , A61K31/4525 , A61K31/505 , A61K31/549 , A61K31/55 , A61K31/7056 , A61K38/00 , A61K38/02 , A61K38/05 , A61K38/14 , A61K45/06 , A61K2300/00 , C07C211/27 , C07C211/30
摘要： A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of Cinacalcet HCl or a pharmaceutical acceptable salt thereof. The cancer is selected from the group consisting of a pleural-related cancer, an abdominal-related cancer, an endocrine-related cancer, a gastrointestinal tract-related cancer, osteosarcoma, skin cancer, and blood cancer.
-
公开(公告)号：US10098852B2
公开(公告)日：2018-10-16
申请号：US15521540
申请日：2015-10-23
发明人： Chiu-Hung Chen , Show-Mei Chuang , Tzong-Der Way , Nai-Wan Hsiao
IPC分类号： A01N31/14 , A61K31/075 , A61K31/085
摘要： A method for treating a cancer includes administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising Monobenzone or a pharmaceutical acceptable salt thereof. The cancer is selected from pleural-related cancer, abdominal-related cancer, endocrine-related cancer, gastrointestinal tract-related cancer, osteosarcoma, and skin cancer. The pleural-related cancer is lung cancer. The abdominal-related cancer is selected from bladder cancer, cervical cancer, and kidney cancer. The endocrine-related cancer is selected from prostate cancer, breast cancer, and ovarian cancer. The gastrointestinal tract-related cancer is selected from gastric cancer, hepatic cancer, colorectal cancer, pancreatic cancer, and tongue cancer.
-
公开(公告)号：US10016390B2
公开(公告)日：2018-07-10
申请号：US15492859
申请日：2017-04-20
发明人： Chiu-Hung Chen , Show-Mei Chuang , Tzong-Der Way , Nai-Wan Hsiao
IPC分类号： A61K31/38 , A61K31/381
摘要： Provided in the present invention are uses of duloxetine hydrochloride in preparing a pharmaceutical composition for treatment of cancer.
-
9.发明申请公开(公告)号：US20170304387A1
公开(公告)日：2017-10-26
申请号：US15521517
申请日：2015-10-23
CPC分类号： A61K31/085 , A61K31/00 , A61K31/137 , A61K31/138 , A61K31/196 , A61K31/197 , A61K31/216 , A61K31/341 , A61K31/366 , A61K31/381 , A61K31/404 , A61K31/4427 , A61K31/4525 , A61K31/505 , A61K31/549 , A61K31/55 , A61K31/7056 , A61K38/00 , A61K38/02 , A61K38/05 , A61K38/14 , A61K45/06 , A61K2300/00 , C07C211/27 , C07C211/30
摘要： A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of an antibiotic drug or a pharmaceutical acceptable salt thereof. The antibiotic drug is selected from the group consisting of an aminoglycoside antibiotic drug, an anti-fungal antibiotic drug, a Cephalosporin antibiotic drug, a β-propionamide antibiotic drug, a chloramphenicol antibiotic drug, an erythromycin antibiotic drug, a penicillin antibiotic drug, and a tetracycline antibiotic drug. The cancer is selected from the group consisting of lung cancer, gastrointestinal tract cancer, colorectal cancer, prostate cancer, bladder cancer, cervical cancer, breast cancer, and blood cancer.
-
公开(公告)号：US20170304218A1
公开(公告)日：2017-10-26
申请号：US15521540
申请日：2015-10-23
发明人： Chiu-Hung Chen , Show-Mei Chuang , Tzong-Der Way , Nai-Wan Hsiao
IPC分类号： A61K31/085
CPC分类号： A61K31/381 , A61K31/00 , A61K31/085 , A61K31/137 , A61K31/138 , A61K31/196 , A61K31/197 , A61K31/216 , A61K31/341 , A61K31/366 , A61K31/404 , A61K31/4427 , A61K31/4525 , A61K31/505 , A61K31/549 , A61K31/55 , A61K31/7056 , A61K38/00 , A61K38/02 , A61K38/05 , A61K38/14 , A61K45/06 , A61K2300/00 , C07C211/27 , C07C211/30
摘要： A method for treating a cancer includes administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising Monobenzone or a pharmaceutical acceptable salt thereof. The cancer is selected from pleural-related cancer, abdominal-related cancer, endocrine-related cancer, gastrointestinal tract-related cancer, osteosarcoma, and skin cancer. The pleural-related cancer is lung cancer. The abdominal-related cancer is selected from bladder cancer, cervical cancer, and kidney cancer. The endocrine-related cancer is selected from prostate cancer, breast cancer, and ovarian cancer. The gastrointestinal tract-related cancer is selected from gastric cancer, hepatic cancer, colorectal cancer, pancreatic cancer, and tongue cancer.
-
-
-
-
-
-
-
-
-
搜索结果
10 条记录 (耗时 0.016 秒)
